Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials-Reference-Cited by-同舟云学术

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

Published:2020-01-01 Issue:1 Volume:36 Page:48-57
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Lathouwers Erkki¹,Wong Eric Y²,Brown Kimberley¹,Baugh Bryan³,Ghys Anne¹,Jezorwski John⁴,Mohsine El Ghazi¹,Van Landuyt Erika¹,Opsomer Magda¹,De Meyer Sandra¹,De Wit S,Florence E,Vandekerckhove L,Vandercam B,Brunetta J,Klein M,Murphy D,Rachlis A,Walmsley S,Ajana F,Cotte L,Girard P-M,Katlama C,Molina J-M,Poizot-Martin I,Raffi F,Rey D,Reynes J,Teicher E,Yazdanpanah Y,Arastéh K,Bickel M,Bogner J,Esser S,Faetkenheuer G,Jessen H,Kern W,Rockstroh J,Spinner C,Stellbrink H-J,Stoehr A,Antinori A,Castelli F,Chirianni A,De Luca A,Di Biagio A,Galli M,Lazzarin A,Maggiolo F,Maserati R,Mussini C,Garlicki A,Gasiorowski J,Halota W,Horban A,Parczewski M,Piekarska A,Belonosova E,Chernova O,Dushkina N,Kulagin V,Ryamova E,Shuldyakov A,Sizova N,Tsybakova O,Voronin E,Yakovlev A,Antela A,Arribas JR,Berenguer J,Casado J,Estrada V,Galindo MJ,Garcia Del Toro M,Gatell JM,Gorgolas M,Gutierrez F,Gutierrez MDM,Negredo E,Pineda JA,Podzamczer D,Portilla Sogorb J,Rivero A,Rubio R,Viciana P,De Los Santos I,Clarke A,Gazzard BG,Johnson MA,Orkin C,Reeves I,Waters L,Benson P,Bhatti L,Bredeek F,Crofoot G,Cunningham D,DeJesus E,Eron J,Felizarta F,Franco R,Gallant J,Hagins D,Henry K,Jayaweera D,Lucasti C,Martorell C,McDonald C,McGowan J,Mills A,Morales-Ramirez J,Prelutsky D,Ramgopal M,Rashbaum B,Ruane P,Slim J,Wilkin A,deVente J,De Wit S,Florence E,Moutschen M,Van Wijngaerden E,Vandekerckhove L,Vandercam B,Brunetta J,Conway B,Klein M,Murphy D,Rachlis A,Shafran S,Walmsley S,Ajana F,Cotte L,Girard P-M,Katlama C,Molina J-M,Poizot-Martin I,Raffi F,Rey D,Reynes J,Teicher E,Yazdanpanah Y,Gasiorowski J,Halota W,Horban A,Piekarska A,Witor A,Arribas JR,Perez-Valero I,Berenguer J,Casado J,Gatell JM,Gutierrez F,Galindo MJ,Gutierrez MDM,Iribarren JA,Knobel H,Negredo E,Pineda JA,Podzamczer D,Portilla Sogorb J,Pulido F,Ricart C,Rivero A,Santos Gil I,Blaxhult A,Flamholc L,Gisslèn M,Thalme A,Fehr J,Rauch A,Stoeckle M,Clarke A,Gazzard BG,Johnson MA,Orkin C,Post F,Ustianowski A,Waters L,Bailey J,Benson P,Bhatti L,Brar I,Bredeek UF,Brinson C,Crofoot G,Cunningham D,DeJesus E,Dietz C,Dretler R,Eron J,Felizarta F,Fichtenbaum C,Gallant J,Gathe J,Hagins D,Henn S,Henry KW,Huhn G,Jain M,Lucasti C,Martorell C,McDonald C,Mills A,Morales-Ramirez J,Mounzer K,Nahass R,Olivet H,Osiyemi O,Prelutsky D,Ramgopal M,Rashbaum B,Richmond G,Ruane P,Scarsella A,Scribner A,Shalit P,Shamblaw D,Slim J,Tashima K,Voskuhl G,Ward D,Wilkin A,de Vente J,

Affiliation:

1. Janssen Pharmaceutica NV, Beerse, Belgium.

2. Janssen Scientific Affairs, LLC, Titusville, New Jersey.

3. Janssen Research & Development LLC, Raritan, New Jersey.

4. Janssen Research & Development, Pennington, New Jersey.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2019.0111

Reference31 articles.